Compare Captisol-Enabled (CE) Budesonide + Azelastine Nasal Solution and Rhinocort Aqua + Astelin in an Environmental Exposure Chamber (EEC) Study of Allergic Rhinitis

PHASE2CompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
Seasonal Allergic Rhinitis
Interventions
DRUG

Budesonide + Azelastine

nasal spray, one spray per nostril at time 0 plus one spray Placebo

DRUG

Budesonide + Azelastine

nasal spray, one spray of each per nostril at time 0

DRUG

Placebo

nasal spray, one spray per nostril from each of 2 bottles at time 0

Trial Locations (1)

L4W 1N2

Allied Research International - Cetero Research, Mississauga

Sponsors
All Listed Sponsors
lead

Ligand Pharmaceuticals

INDUSTRY